118 studies found for:    "Gout"
Show Display Options
Download search resultsDownload the search results for:
"Gout" (118 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout
Conditions: Gout;   Gout Acute
Interventions: Drug: Allopurinol;   Drug: Placebo
2 Withdrawn Allopurinol in Acute Gout
Condition: Gout
Intervention: Drug: allopurinol
3 Completed
Has Results
Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout
Condition: Gout
Intervention: Biological: Pegloticase
4 Completed Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management
Condition: Gout
Intervention:
5 Completed Long Term Study of Canakinumab (ACZ885) in Patients With Gout
Condition: Gout
Intervention: Drug: Canakinumab
6 Completed Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
Condition: Gout
Interventions: Biological: Rilonacept;   Other: Placebo
7 Completed
Has Results
Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout
Condition: Gout
Intervention: Biological: pegloticase
8 Completed
Has Results
Evaluating Efficacy of Canakinumab (ACZ885) in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy
Condition: Gout
Interventions: Drug: Canakinumab 25 mg;   Drug: Canakinumab 50 mg;   Drug: Canakinumab 100 mg;   Drug: Canakinumab 200 mg;   Drug: Canakinumab 300 mg;   Drug: Canakinumab repeated every 4 week (q4wk);   Drug: Colchicine;   Drug: Allopurinol;   Drug: Placebo Matching Canakinumab;   Drug: Placebo Matching Colchicine
9 Completed PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)
Condition: Gout
Interventions: Drug: placebo;   Drug: rilonacept
10 Completed Does Allopurinol Prolong a Treated, Acute Gout Flare?
Condition: Gout
Interventions: Drug: allopurinol;   Drug: Placebo (sugar pill)
11 Completed Safety and Efficacy of Oral Febuxostat in Subjects With Gout
Condition: Gout
Interventions: Drug: Febuxostat;   Drug: Allopurinol
12 Enrolling by invitation Lesinurad and Febuxostat Combination Extension Study in Gout
Condition: Gout
Intervention: Drug: lesinurad
13 Recruiting Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
Condition: Gout
Interventions: Drug: PF-06743649;   Other: Placebo
14 Completed Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Condition: Gout
Interventions: Drug: lesinurad;   Drug: Placebo
15 Completed Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life
Condition: Gout
Intervention:
16 Unknown  Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Intervention: Drug: levotofisopam
17 Completed A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
Condition: Gout
Intervention: Drug: Puricase
18 Completed Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
Condition: Gout
Interventions: Drug: placebo;   Drug: BCX4208
19 Completed Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
Conditions: Hyperuricemia;   Gout
Interventions: Drug: Arhalofenate;   Drug: Febuxostat
20 Completed A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
Conditions: Gout;   Hyperuricemia;   Arthritis;   Joint Disease;   Renal Insufficiency
Interventions: Drug: Placebo;   Drug: Ulodesine (BCX4208) 5 mg;   Drug: Ulodesine (BCX4208) 10 mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years